发明授权
- 专利标题： Crystalline form E of tafamidis meglumine, process for preparation and use thereof
-
申请号： US16098586申请日： 2017-05-05
-
公开(公告)号： US10577334B2公开(公告)日： 2020-03-03
- 发明人: Minhua Chen , Yanfeng Zhang , Jiaoyang Li , Xiaoyu Zhang
- 申请人： Crystal Pharmatech Co., Ltd.
- 申请人地址： CN Suzhou
- 专利权人： Crystal Pharmatech Co., Ltd.
- 当前专利权人： Crystal Pharmatech Co., Ltd.
- 当前专利权人地址： CN Suzhou
- 代理机构： McCarter & English, LLP
- 代理商 Steven G. Davis; Wei Song
- 优先权： CN201610293338 20160505
- 国际申请： PCT/CN2017/083177 WO 20170505
- 国际公布： WO2017/190682 WO 20171109
- 主分类号： C07D263/57
- IPC分类号： C07D263/57 ; C07C215/40 ; A61K31/423 ; A61P25/28
摘要：
The present disclosure relates to a novel crystalline form E of Tafamidis meglumine, process for preparation and use thereof. When compared with prior crystalline forms, the novel crystalline form of the present disclosure has the advantages of simple process and low hygroscopicity, which provides a new and better choice for the development of Tafamidis meglumine drug product and is of great significance.
公开/授权文献
信息查询
